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Background: Inflammatory mediators can serve as biomarkers for the monitoring of the disease progression or
prognosis in many conditions. In the present study we introduce an adaptation of a membrane-based technique in
which the level of up to 40 cytokines and chemokines can be determined in both human and rodent blood in a
semi-quantitative way. The planar assay was modified using the LI-COR (R) detection system (fluorescence based)
rather than chemiluminescence and semi-quantitative outcomes were achieved by normalizing the outcomes using
the automated exposure settings of the Odyssey readout device. The results were compared to the gold standard
assay, namely ELISA.
Results: The improved planar assay allowed the detection of a considerably higher number of analytes (n = 30 and
n = 5 for fluorescent and chemiluminescent detection, respectively). The improved planar method showed high
sensitivity up to 17 pg/ml and a linear correlation of the normalized fluorescence intensity with the results from the
ELISA (r = 0.91).
Conclusions: The results show that the membrane-based technique is a semi-quantitative assay that correlates
satisfactorily to the gold standard when enhanced by the use of fluorescence and subsequent semi-quantitative
analysis. This promising technique can be used to investigate inflammatory profiles in multiple conditions,
particularly in studies with constraints in sample sizes and/or budget.
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There is a large body of evidence supporting the use of
inflammatory mediators as putative biomarkers for the
early detection of a variety of diseases such as heart failure,
cancer and infections [1-3]. Hence, determining changes
in the levels of inflammatory markers in patients using
multimarker-based strategies is expected to lead to better
care [4].
In the last decade, multiplex cytokine arrays have become
available in a bead-based (or suspension) format showing
advantages over the more conventional immunoassays that* Correspondence: r.altara@maastrichtuniversity.nl
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unless otherwise stated.rely on a solid support [5]. The principle of this assay is
quite similar to that of the classic ELISA [6], but the
primary antibodies are conjugated to color-coded mi-
cro beads rather than ELISA plates and the secondary
antibody is attached to a fluorophore. The detection is
based on dual-laser flow-based reading where a special
instrument classifies the beads and subsequently deter-
mines the intensity of the fluorophore, the latter reflecting
the concentration of the analytes bound to the beads. Not-
withstanding the beauty of the bead-based technology,
cases of a loss of sensitivity have been reported [7], result-
ing in certain proteins becoming undetectable in blood.
An alternative method for simultaneous detection and
quantification is a planar assay known as fluorescence-
linked immunosorbent assay (FLISA). This assay differs
from the ELISA, in that the secondary antibodies aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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tensities emitted by the fluorophore labeled anti-biotin
reporters. The sensitivity of this assay is higher than a
traditional ELISA and it may be enhanced even further
using tyramide signal amplification [8]. FLISA detec-
tion is usually suitable for concentrations that are nor-
mally present in the low pg/mL range, however it is
recommended for the detection of limited number of
targets as the optimization can be difficult using this
format.
In this manuscript we report an improved planar multi-
plex assay (Proteome Profiler™). The assay is membrane-
based and its protocol also resembles the ELISA principle.
Primary antibodies are conjugated to a nitrocellulose
membrane in confined spots. A sample pre-incubated
with a secondary antibody is then added to the mem-
branes. This assay has been marketed by the manufac-
turer as a qualitative assay; hence, the membranes
should be processed according to a classic Western blot
protocol and the results provide information of the
presence of an analyte rather than about its amount.
In this manuscript, we present the fluorescent readout
of the membranes which substantially increases the sen-
sitivity of the procedure. Moreover, the introduction of
an automated procedure to normalize the readout from
the analytes allowed us to obtain semi-quantitative
results. We evaluated the sensitivity and accuracy of the
membrane-based immunoassay and compared the re-
sults with those obtained by ELISA. Moreover, we showed





This study was carried out in accordance with the rec-
ommendations in the Guidelines for the Care and Use
of Laboratory Animals of the Dutch Institutes of Health.
The protocol was approved by the Committee on the Ethics
of Animal Experiments of the University of Maastricht.
All surgery was performed under isoflurane anesthesia,
and all efforts were made to minimize suffering.
Human research
The recruitment of healthy volunteers was performed ac-
cording to the Dutch Medical Ethical Committee (proto-
col: METC 11-3-056) and in respect of the Declaration of
Helsinki. The individuals in this manuscript have given
written informed consent to publish these case details.
Transverse Aortic Constricted (TAC) Mouse
Pressure overload was induced in male C57BL/6 J mice
(Harlan Laboratories, Boxmeer, The Netherlands; N = 5)
as previously described [9]. Control male C57BL/6 J mice(Sham; N = 5) underwent the same surgical procedure
without the actual tightening of the ligature. Animals were
sacrificed four weeks after the Sham or TAC operation
and blood samples were collected.
LPS treated rats
Male Wistar rats (N = 5) were treated, under isoflurane
anesthesia, with LPS (Sigma-Aldrich) (0.5 mg/kg) intra-
venously to induce an acute systemic inflammatory re-
sponse, and were sacrificed after 30 minutes. For the
semi-quantitative test serum from the animals was pooled.
A total amount of 1000 μL was used in the membrane-
based assay, while a total amount of 50 μL of serum per




Blood was sampled from the abdominal aorta during
sacrifice. It was then allowed to clot for 4 hours at 4°C
before centrifuging for 10 minutes at 2000 g. Serum was
removed and immediately aliquoted and stored (for
6 months on average) at < -80°C.
Plasma
Blood was sampled from the abdominal aorta during sac-
rifice. Plasma was collected using EDTA as an anticoagu-
lant. It was stored for 2 hours at 4°C and centrifuged for
10 minutes at approximately 2000 g. Plasma was removed
and immediately aliquoted and stored (for 6 months on
average) at < -80°C.
Membrane stripping
A pool of serum obtained from five TAC mice (200 μL
for each) was tested according to the original Proteome
Profiler™ Antibody Array based on chemiluminescence.
Subsequently, stripping of the secondary antibody was
performed by rinsing the membranes three times for
10 minutes with MilliQ water at 70°C. Then the new
protocol for fluorescence detection, described in this
manuscript (see below), was performed on the stripped
membranes.
TNF-α detection via Enzyme Linked Immunosorbent
Assay (ELISA)
Rat TNF-α Quantikine ELISA Kit was purchased from
R& D Systems, Minneapolis MN, USA. The assay was
performed following the manufacturer’s instructions.
Proteome Profiler™ Antibody Array: membrane-based
assay
Mouse, rat and human Cytokine Array Panel A (R& D Sys-
tems) were used according to the manufacturer’s instruc-
tions (see the Extracellular Factors session on http://www.
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ProfilerArray.aspx) until step #9 (Incubate overnight at 2 -
8°C on a rocking platform).
The following modifications of the original protocol
were made to adapt it for fluorescence read-out:
1. Carefully remove the membranes and place them
into individual plastic containers. Gently wash the
membranes with 20 mL of Wash Buffer 1× for
10 min on platform shaker. Repeat the procedure 3
times.
2. Discard the washing buffer and rinse the membranes
with 20 mL of blocking solution [Odyssey Blocking
Buffer (LI-COR Bioscience, Lincoln NE, USA) and
PBS 1× - (1:1)] for 15 minutes on a rocking
platform.
3. Every membrane is incubated with 5 mL blocking
solution pre-mixed with 3.3 μL IRDye® 800CW
Streptavidin (pre-diluted 1:100, LI-COR Bioscience)
in 50 mL plastic tubes.
4. Tubes are then placed for 1 hr on a rolling bench
protected from the light.
5. Wash the membranes 3 times with PBS 1×
supplemented with 0.15%-Tween for 10 minutes.
6. Rinse 4 times with PBS 1×.
7. Leave the membranes to dry on paper in a dark
place.
8. Scan with the LI-COR Odyssey infrared imaging
scanner (Westburg BV, Leusden, The Netherlands).
Resolution: 84 μm
Quality: High
Focus offset: 0.0 mm
Intensity: 5, adjust as necessary. Avoid overexposure
of the membrane. White dots (bleaching) should not
appear on the final acquisition.
9. Background subtraction was performed by setting
the negative controls of each independent
membrane to 0.
NB. The Odyssey imaging scanner adjusts the exposure
time automatically upon the signal intensity set. It has de-
fault scanning presets. The user can choose from 5 set-
tings through the “quality” option: Lowest, Low, Medium,
High and Highest. The settings indicated under point 8
are therefore necessary to have the correct setup, allowing
normalization of the data later on.Standard curve with human recombinant proteins
Recombinant Human IL-1 beta and Recombinant Human
CXCL10/IP-10 from R& D Systems (R& D Systems™) were
reconstituted according to the manufacturer’s instructions.
Following the reconstitution, the analytes were diluted to
generate their respective stock solution.The stock solutions were used to generate the following
standard curves:
Concentrations (pg/mL): 1000, 500, 250,125, 62.5,
31.25.
Human IL-1 beta/IL-1 F2 Quantikine ELISA Kit and
Human CXCL10/IP-10 Quantikine ELISA Kit (R& D
Systems™) were used to quantify the analytes for further
comparison with the Proteome Profiler™ outcome.
Statistical methods/data analysis
Mouse/rat data
All data included in this manuscript are expressed in
units according to the international system. After back-
ground subtraction, polynomial curve fitting was used
to infer the calibration curve for each membrane using
Prism5 (GraphPad Software, Inc.; La Jolla CA, USA)
and R [10]. Linear regression was used to test the co-
linearity between ELISA and the membrane-based assay
read-outs. The results are illustrated by bar and scatter
plots.
Human data
Raw data have been imported in R. Background was sub-
tracted from raw data for each membrane. The readouts
of the membranes have been tested for a linear relation-
ship with the predicted concentrations by use of the
MASS package (‘Modern Applied Statistics with S’ (4th
edition, 2002)). Study of the quality of predictions was
performed by gvlma (Global Validation of Linear Models
Assumptions).
Results
Comparison of fluorescence and chemiluminescence
detection
In Figure 1, two membranes that first were developed by
chemiluminescence and then re-developed after stripping
of the streptavidin-enzyme complex from the biotinylated
secondary antibody are shown. The number of spots
that could be detected, even visually, appeared to be 6-
fold higher following the fluorescent (n = 30) compared
to the chemiluminescent (n = 5) detection method. As
a result, the membrane-based technique allowed the
detection of the robust increase of at least 4 analytes
(MIG, IP-10, MIP-2 and IL-17) out of the 30 detectable
inflammatory mediators present in pooled serum samples
of five TAC operated mice with similar hemodynamic
characteristics.
Comparison of the membrane-based assay with
fluorescence detection to ELISA
In order to prove the feasibility of the optimized
membrane-based technology as a semi-quantitative assay,
biological samples already containing high levels of cytokines
were used for validation. For this purpose, a consecutive
Figure 1 Comparison of chemiluminescence and fluorescence detection. In the left panel, chemiluminescence and fluorescence images,
obtained from the same membrane after stripping, are represented. The latter method yielded a considerably higher number of detectable
analytes that can be visualized (green spots). The fluorescence readout allowed to compare the circulating inflammatory profile of pooled
samples (200 μL each) of 5 TAC operated mice to the relative shams (see graph in the right box).
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TNF-α was measured using both the membrane-based
assay and ELISA. As shown in Figure 2a, the fluores-
cence intensity (FI) decreased linearly with increased
dilution. Moreover, the correlation of the fluorescence
intensity with the serum concentration determined by
ELISA was Pearson’s r = 0.91 (Figure 2b).
Applicability to human cytokines
As proof of concept of the translatability of the fluores-
cent protocol to human research, a series of tests on
consecutive dilutions of known cytokines in buffer were
assayed. As shown in Figure 3, the Fluorescence Inten-
sity (FI) readout of the membranes was almost co-linear
with the predicted concentrations (Pearson’s r value of
0.98 and 0.91 for IL-1β and IP-10, respectively). Testing
the model (Predicted concentrations ~Membrane read-
outs) fitting to detect biases and to check the overall
quality of the distribution also gave promising results
(Figure 4). The residuals vs. fitted values appeared to be
skewed towards the low values. Overall, these resultsindicate that the residuals behave randomly, suggesting
that the model fits the data well.
Discussion
In the present study, we show the superior sensitivity of
fluorescence over chemiluminescence detection of a
membrane-based assay for inflammatory mediators. Al-
though this assay is intended for qualitative use by the
manufacturer, we improved it using a fluorescence
reporter system and a near-infrared imaging device to
acquire the signal, and showed that the assay could be
upgraded to yield semi-quantitative data (see Figure 5).
We demonstrate that by normalizing the readouts to
the background reference spots present on each mem-
brane and using specific instrument settings the readout
becomes semi-quantitative and shows a strong correl-
ation with the outcomes of ELISA. Our adaptations
make the membrane-based analysis suitable for use in
situations where the amount of sample is limited, as in-
formation of ~30 analytes could be obtained from only
1 mL of serum.
Figure 2 Membrane-based cytokine arrays as semi-quantitative assay. (a) TNF-α signal derived from the membrane-based assay for six
progressive dilutions of a pool of plasma obtained from two LPS treated rats. The concentrations range from 930 to 18 pg/mL (from left to right).
In b, the correlation between the membrane-based assay intensity and ELISA concentration detected for the same samples measured with the
two different techniques is shown. The red dashed lines delimited the 95% confidence interval.
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screening and detection of a large number of circulating
inflammatory mediators in an in-vivo model for circulat-
ing cytokines/chemokines, which would be limited in
conventional ELISAs due to sample availability and/or
cost. Indeed, small animal models are known to yield
low sample volumes, so to perform multiple ELISAs a
large amount of animals would be necessary. Besides, to
perform up to 40 classical ELISA investigations it would
be rather laborious and costly.
In this study, a model of cardiovascular disease has
been used to test the screening performance of the im-
proved membrane-based assay on pooled samples ob-
tained from mice. The TAC mouse model used isactually a known model for cardiac hypertrophy and it
is conclusively proved that inflammation becomes acti-
vated [11,12] during cardiac remodeling. Moreover, the
cardiac inflammatory mediators are released into the
circulation [13], but the complete list of all the inflam-
matory mediators that are circulating in blood is still
far from complete. In our investigation we obtained
evidence that novel analytes (i.e. MIG and IP-10) can
be found in the circulation of mice exposed to TAC for
4 weeks, giving to us a starting point for future investiga-
tions. However, our experimental approach (chemilumin-
escent detection- stripping –fluorescent detection) may
have affected the actual inflammatory profile. Indeed, the
efficiency of the stripping and the protein loss during that
Figure 3 Curve fitting for IL-1β and IP-10. Visualization of the regression line (blue) fitted for the theoretical concentrations and membrane’s
fluorescence readouts of IL-1β (a) and IP-10 (b). The dots are compactly distributed around the predicted line, and the unexplained error is small.
The red lines delimited the 95% of CI. The equations of the curves are: a) y = 561.73 × + 8.97 with Pearson’s r = 0.97; b) y = 1830.6 × – 79.4 with
Pearson’s r = 0.91. The red dashed lines delimited the 95% confidence interval.
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need to be interpreted with caution, as the observed in-
flammatory profile may not reflect the actual one that is
present in mice after 4 weeks of TAC.
In this study we are the first to introduce the versatil-
ity of the membrane-based assay, commercially known
as Proteome Profiler, as a multiplex detecting assay for
semi-quantitative analysis of inflammatory mediators.Figure 4 Model diagnostics of the curve fitting of IL-1β (a) and IP-10
appears in the residuals distribution for concentrations below 400 ng/mL. T
Whilst this does not affect the goodness of the coefficient estimation, it im
The Cook’s distance suggests that 2 of the most diluted samples could be co
distance has no unambiguous interpretation and the best decision is to look
indication of anomalous position. The red dashed lines delimited the 95% ofThe use of the fluorescence detection protocol allowed
us to accurately read the intensity of the spots at stan-
dardized exposure times (see materials and methods)
which in turn allowed us to create a normalization
protocol. The distinct advantages were that the mea-
surements could be repeated without variation (data not
shown) and the reading outcomes were comparable
among the membranes, as the “development procedure”(b)."Residuals vs. Fitted" and "Scale-Location" show that a trend
he “Q-Q plot” suggests that residuals are not normally distributed.
pairs the t-distribution and thus renders the use of p-values meaningless.
nsidered outliers in their influence on the model fitting. However, Cook’s
at the original distribution, where the 2 incriminated points show no
CI.
Figure 5 Schematic representation of the main differences between the Proteome Profiler intended for chemiluminescence and the
fluorescent detection method and semi-quantitative analysis protocol proposed in this manuscript.
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struction of concentration curves with satisfactory re-
sults when it came to linearity (Figures 2 and 3).
One of the reasons that drove us to implement the
membrane-based technique was to test whether it was
possible to avoid the “hook effect”. This effect is a
phenomenon that can occur in multiplex immune-assays
when the level of the analyte of interest is close to the
lower detection limit; hence the signal to noise ratio is
too low and the readouts corrected for the dilution fac-
tor result in an overestimation of the actual concen-
tration. In previous experiments performed using the
multiplex bead-based technology, we ran into such ar-
tifacts in several cases (data not shown). We observed
that the detection of many inflammatory mediators in
rodent blood was impaired and therefore this approach
was only useful for the detection of analytes with high
circulating levels.
To test the performance of our adapted membrane-
based assay at low analyte concentrations, we tested ourmodel (Predicted concentrations ~Membrane readouts)
fitting to detect biases and to check the overall quality
of the distribution also at very low side of the curve
(Figure 4). Below 200 pg/mL the residuals diverged,
possibly showing a technical limitation of the mem-
brane based assay. In fact, the residuals did not show
any co-linearity with the fitted values, and the residuals
versus leverage plots showed a well-behaved test. This
behavior suggests that there is room for technical devel-
opment to improve the reliability of the assay at low
concentrations.
Conclusion
We present the potential use of a planar method as
multiplex assay for the identification of a large panel of
inflammatory mediators in blood. By switching from the
chemiluminescent to the fluorescent readout and adapting
our detection protocol, we showed that a membrane-
based assay can yield semi-quantitative results for the de-
tection of multiple cytokines and chemokines in mouse,
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ising technique will allow scientists from several fields to
extend their investigations in a prominent way, particu-
larly when an inventory of multiple inflammatory markers
is needed in a setting of low sample sizes and/or budget
constraints. Considering the outcome of this study and
what we known from the commercially available kits for
cytokine/chemokine determination, we present a descrip-
tive table that summarizes the major pros and cons of the
assay with the respect to the two commonly alternative
methods (see Additional file 1: Table S1).
Additional file
Additional file 1: Table S1. Advantages and disadvantages of the
existing immunoassays kits for cytokines/chemokines determination.
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